missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CEACAM7 (aa 229-250) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (55%), Rat (55%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-140265 (PA5-140265. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
CEACAM7 is a CEA-related cell adhesion molecule 7 that belongs to the carcinoembryonic antigen (CEA) family. CEACAM7 encodes a glycosyl phosphatidyl inositol (GPI)-linked glycoprotein which is only found on the apical surface of highly differentiated epithelial cells adult colon and on a small epithelial cell population in pancreatic ducts. CEACAM7 expression is completely lost upon malignant transformation already in hyperplastic polyps and early adenomas as well as in adenocarcinomas of the colon. Like all members of the CEACAM family, it consists of a single N domain, with structural homology to the immunoglobulin variable domains, followed by one immunoglobulin constant-like A domain.
Specifications
Specifications
| Accession Number | Q14002 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 1087 |
| Name | Human CEACAM7 (aa 229-250) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | BGP; BGP7; carcinoembryonic antigen CGM2; carcinoembryonic antigen gene family member 2; carcinoembryonic antigen related cell adhesion molecule 7; carcinoembryonic antigen-related cell adhesion molecule 7; CEA; CEACAM7; CGM2 |
| Common Name | CEACAM7 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction